Completed
A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women
NCT01059435
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
- Locations
-
Not specified